rs892119
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001626.6(AKT2):c.287+993G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 132,644 control chromosomes in the GnomAD database, including 2,251 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.19 ( 2251 hom., cov: 30)
Consequence
AKT2
NM_001626.6 intron
NM_001626.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.83
Publications
19 publications found
Genes affected
AKT2 (HGNC:392): (AKT serine/threonine kinase 2) This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019]
AKT2 Gene-Disease associations (from GenCC):
- hypoinsulinemic hypoglycemia and body hemihypertrophyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- diabetes mellitus, noninsulin-dependentInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- AKT2-related familial partial lipodystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- type 2 diabetes mellitusInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.191 AC: 25277AN: 132520Hom.: 2243 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
25277
AN:
132520
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.191 AC: 25316AN: 132644Hom.: 2251 Cov.: 30 AF XY: 0.191 AC XY: 12330AN XY: 64566 show subpopulations
GnomAD4 genome
AF:
AC:
25316
AN:
132644
Hom.:
Cov.:
30
AF XY:
AC XY:
12330
AN XY:
64566
show subpopulations
African (AFR)
AF:
AC:
8452
AN:
40940
American (AMR)
AF:
AC:
2157
AN:
12040
Ashkenazi Jewish (ASJ)
AF:
AC:
507
AN:
3120
East Asian (EAS)
AF:
AC:
701
AN:
4266
South Asian (SAS)
AF:
AC:
502
AN:
3284
European-Finnish (FIN)
AF:
AC:
2055
AN:
9000
Middle Eastern (MID)
AF:
AC:
43
AN:
252
European-Non Finnish (NFE)
AF:
AC:
10324
AN:
57092
Other (OTH)
AF:
AC:
338
AN:
1824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1050
2100
3149
4199
5249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
419
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.